Status:

NOT_YET_RECRUITING

Better4All Personalized Intervention

Lead Sponsor:

Harokopio University

Collaborating Sponsors:

University of Navarra

CENTRO DE ESTUDOS E INVESTIGACAO EM DINAMICAS SOCIAIS E SAUDE ASSOCIACAO SEM FINS LUCRATIVOS

Conditions:

Obesity Prevention

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The BETTER4U (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you) project, funded by the European Union, aims to address obesity through biologically and behaviour...

Detailed Description

Obesity is a major global public health issue with significant physical, psychosocial, and financial implications, especially in vulnerable populations. It results from complex interactions between ge...

Eligibility Criteria

Inclusion

  • Age: Participant aged 18-65 years
  • Body Mass Index (BMI): BMI ≥ 25 kg/m² (overweight or obesity)
  • Willingness and ability to use wearable devices and an Android mobile application for the duration of the study
  • Owning a smartphone device with Android operating system
  • Eating utensil technique: dominant hand gestures that correspond to handling of food via a fork or a spoon
  • Language proficiency: participant has the ability to read and understand the language in which the mobile app and study materials are provided
  • Consent: participant is willing to provide informed consent to participate in the study
  • Residency: participant is resident of the country
  • Availability: participant is able to participate for the full three-week duration of the study and comply with the study protocol

Exclusion

  • Pregnant or breastfeeding or intending to get pregnant in the short-term
  • Comorbidities which might affect inflammation levels (i.e. type 1 diabetes, uncontrolled type 2 diabetes, unstable cardiovascular disease, eating disorders, gastrointestinal disorders)
  • Mental illness affecting cognitive and communication skills, lifestyle and/or dietary habits
  • History of cancer within 5 years prior to intervention onset
  • Physical Limitations: any physical or mental condition that would prevent the participant from using the wearable device or mobile application as intended
  • Any other criterion which would deem the participant unsuitable, according to the investigator's impression
  • Technical Incompatibility: Individual does not own a compatible smartphone or are unable to use the provided wearable devices for technical reasons
  • Documented and/or self-reported rapid changes in body weight in the six months preceding intervention onset, attributed to a diagnosed medical condition
  • Interventional drug treatment in a clinical trial in the period within six months prior to intervention onset, which might affect intervention impact
  • Inability to adhere to the proposed diet regimens, due to medical (i.e. gluten intolerance, allergies, swallowing problems) or religious reasons
  • Medication promoting weight loss
  • Bariatric surgery in the 12 months preceding intervention onset
  • Use of supplements promoting weight loss or sleep quality, mood enhancing supplements, and/or consumption of probiotics and medications that influence the microbiome in the last three months preceding intervention onset Participation in a different clinical trial protocol or participation in different programs aiming at weight loss during the six months preceding intervention onset

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2027

Estimated Enrollment :

1022 Patients enrolled

Trial Details

Trial ID

NCT06997510

Start Date

October 1 2025

End Date

April 1 2027

Last Update

May 30 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

University of Cyprus (Ucy)

Nicosia, Cyprus, 2109

2

Universite Lyon 1 Claude Bernard (Ucbl)

Villeurbanne, France, 69622 CEDEX

3

Harokopio University

Athens, Aticca, Greece, 17676

4

Uniwersytet Swps (Swps)

Wroclaw, Poland, 53-238